Haemonetics Corp reports results for the quarter ended in December - Earnings Summary

Haemonetics

07/02/2023 12:01

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
85 cents​​ per share for the quarter ended in December. The mean
expectation of eight analysts for the quarter was for earnings
of 80 cents per share.
    * Revenue rose 17.5% to $305.30 million from a year ago;
analysts
expected $300.47 million. 
    * Haemonetics Corp's reported EPS for the quarter was 64
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Haemonetics Corp shares had risen by 11.6% this quarter.
    * The company reported quarterly net income of $32.94
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $94.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
7 at 12:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.80           0.85           Beat
 Sep. 30 2022      0.67           0.83           Beat
 Jun. 30 2022      0.51           0.58           Beat
 Mar. 31 2022      0.60           0.65           Beat